David M. Epstein
2021
In 2021, David M. Epstein earned a total compensation of $5.1M as President and Chief Executive Officer at Black Diamond Therapeutics, a 32% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $228,735 |
|---|---|
| Option Awards | $4,235,494 |
| Salary | $538,201 |
| Other | $87,795 |
| Total | $5,090,225 |
Epstein received $4.2M in option awards, accounting for 83% of the total pay in 2021.
Epstein also received $228.7K in non-equity incentive plan, $538.2K in salary and $87.8K in other compensation.
Rankings
In 2021, David M. Epstein's compensation ranked 2,566th out of 12,415 executives tracked by ExecPay. In other words, Epstein earned more than 79.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,566 out of 12,415 | 79th |
Division Manufacturing | 1,021 out of 5,501 | 81st |
Major group Chemicals And Allied Products | 394 out of 2,371 | 83rd |
Industry group Drugs | 345 out of 2,092 | 84th |
Industry Biological Products, Except Diagnostic Substances | 105 out of 449 | 77th |
Source: SEC filing on April 28, 2022.
Epstein's colleagues
We found three more compensation records of executives who worked with David M. Epstein at Black Diamond Therapeutics in 2021.